Chronic e-cigarette exposure alters the human bronchial epithelial proteome

American Journal of Respiratory and Critical Care Medicine

Volumn 198, Issue 1, 2018, Pages 67-76

  Ghosh, Arunava ^a   Coakley, Raymond C ^a   Mascenik, Teresa ^a   Rowell, Temperance R ^a   Davis, Eric S ^a   Rogers, Keith ^a   Webster, Megan J ^a   Dang, Hong ^a   Herring, Laura E ^a   Sassano, M Flori ^a   Livraghi Butrico, Alessandra ^a   Van Buren, Scott K ^b   Graves, Lee M ^a   Herman, Melissa A ^a   Randell, Scott H ^a   Alexis, Neil E ^a   Tarran, Robert ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b IL   (United States)

Author keywords

Chronic obstructive pulmonary disease; Mucin; Tobacco; Vaping

Indexed keywords

ANOCTAMIN 1; CYTOCHROME P450 1B1; MUCIN 4; MUCIN 5AC; MUCIN 5B; N ETHYLMALEIMIDE SENSITIVE FACTOR; PROTEOME; NICOTINE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY MASS; BRONCHUS BIOPSY; BRONCHUS EPITHELIUM; CIGARETTE SMOKING; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ELECTRONIC CIGARETTE; FEMALE; FIBEROPTIC BRONCHOSCOPY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LAVAGE FLUID; LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY; LONG TERM EXPOSURE; MALE; MOUSE; NONHUMAN; NOSE EPITHELIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; VAPING; BRONCHUS; DRUG EFFECT; EPITHELIUM CELL; LUNG; MIDDLE AGED; SMOKING;

ADULT; BRONCHI; ELECTRONIC NICOTINE DELIVERY SYSTEMS; EPITHELIAL CELLS; FEMALE; HUMANS; LUNG; MALE; MIDDLE AGED; NICOTINE; PROTEOME; SMOKERS;

EID: 85047871949     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201710-2033OC     Document Type: Article

References (57)

1. Grana R, Benowitz N, Glantz S. Background paper on e-cigarettes (electronic nicotine delivery systems). San Francisco: UCSF Center for Tobacco Control Research and Education; 2013 [accessed 2018 Jan 1]. Available from: Https://escholarship.org/uc/item/13p2b72n.
2. Benowitz NL. Pharmacology of nicotine: Addiction and therapeutics. Annu Rev Pharmacol Toxicol 1996;36:597-613.
3. Caramori G, Adcock IM, Casolari P, Ito K, Jazrawi E, Tsaprouni L, et al. Unbalanced oxidant-induced DNA damage and repair in COPD: A link towards lung cancer. Thorax 2011;66:521-527.
4. Fischer BM, Pavlisko E, Voynow JA. Pathogenic triad in COPD: Oxidative stress, protease-antiprotease imbalance, and inflammation. Int J Chron Obstruct Pulmon Dis 2011;6:413-421.
5. Messner B, Bernhard D. Smoking and cardiovascular disease: Mechanisms of endothelial dysfunction and early atherogenesis. Arterioscler Thromb Vasc Biol 2014;34:509-515.
6. Yao H, Rahman I. Current concepts on the role of inflammation in COPD and lung cancer. Curr Opin Pharmacol 2009;9:375-383.
7. Zhou-Suckow Z, Duerr J, Hagner M, Agrawal R, Mall MA. Airway mucus, inflammation and remodeling: Emerging links in the pathogenesis of chronic lung diseases. Cell Tissue Res 2017;367:537-550.
8. Rom O, Pecorelli A, Valacchi G, Reznick AZ. Are E-cigarettes a safe and good alternative to cigarette smoking?. Ann N Y Acad Sci 2015;1340: 65-74.
9. Burstyn I. Peering through the mist: Systematic review of what the chemistry of contaminants in electronic cigarettes tells us about health risks. BMC Public Health 2014;14:18.
10. Nutt DJ, Phillips LD, Balfour D, Curran HV, Dockrell M, Foulds J, et al. E-cigarettes are less harmful than smoking. Lancet 2016;387: 1160-1162.
11. Farsalinos KE, Voudris V, Poulas K. Are metals emitted from electronic cigarettes a reason for health concern? A risk-assessment analysis of currently available literature. Int J Environ Res Public Health 2015; 12:5215-5232.
12. Goniewicz ML, Knysak J, Gawron M, Kosmider L, Sobczak A, Kurek J, et al. Levels of selected carcinogens and toxicants in vapour from electronic cigarettes. Tob Control 2014;23:133-139.
13. Hahn J, Monakhova YB, Hengen J, Kohl-Himmelseher M, Schüssler J, Hahn H, et al. Electronic cigarettes: Overview of chemical composition and exposure estimation. Tob Induc Dis 2014;12:23.
14. McNeill A, Brose LS, Calder R, Hitchman SC, Hajek P, McRobbie H. E-cigarettes: An evidence update. London: Public Health England; 2015. PHE Publications Gateway Number 2015260.
15. U.S. Department of Health and Human Services. E-cigarette use among youth and young adults: A report of the Surgeon General. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2016 [accessed 2018 Jan 1]. Available from: Https://e-cigarettes. surgeongeneral.gov/documents/2016-sgr-full-report-non-508.pdf.
16. Bahl V, Lin S, Xu N, Davis B, Wang YH, Talbot P. Comparison of electronic cigarette refill fluid cytotoxicity using embryonic and adult models. Reprod Toxicol 2012;34:529-537.
17. Lerner CA, Sundar IK, Yao H, Gerloff J, Ossip DJ, McIntosh S, et al. Vapors produced by electronic cigarettes and e-juices with flavorings induce toxicity, oxidative stress, and inflammatory response in lung epithelial cells and in mouse lung. PLoS One 2015;10:e0116732.
18. Schweitzer KS, Chen SX, Law S, Van Demark M, Poirier C, Justice MJ, et al. Endothelial disruptive proinflammatory effects of nicotine and e-cigarette vapor exposures. Am J Physiol Lung Cell Mol Physiol 2015;309:L175-L187.
19. Haswell LE, Baxter A, Banerjee A, Verrastro I, Mushonganono J, Adamson J, et al. Reduced biological effect of e-cigarette aerosol compared to cigarette smoke evaluated in vitro using normalized nicotine dose and RNA-seq-based toxicogenomics. Sci Rep 2017;7: 888.
20. Foy JW, Bombick BR, Bombick DW, Doolittle DJ, Mosberg AT, Swauger JE. A comparison of in vitro toxicities of cigarette smoke condensate from Eclipse cigarettes and four commercially available ultra low-"tar" cigarettes. Food Chem Toxicol 2004;42:237-243.
21. Martin EM, Clapp PW, Rebuli ME, Pawlak EA, Glista-Baker E, Benowitz NL, et al. E-cigarette use results in suppression of immune and inflammatory-response genes in nasal epithelial cells similar to cigarette smoke. Am J Physiol Lung Cell Mol Physiol 2016;311:L135-L144.
22. McConnell R, Barrington-Trimis JL, Wang K, Urman R, Hong H, Unger J, et al. Electronic cigarette use and respiratory symptoms in adolescents. Am J Respir Crit Care Med 2017;195:1043-1049.
23. Reidel B, Radicioni G, Clapp P, Ford AA, Abdelwahab S, Rebuli ME, et al. E-cigarette use causes a unique innate immune response in the lung involving increased neutrophilic activation and altered mucin secretion. Am J Respir Crit Care Med 2018;197:492-501.
24. American Thoracic Society; Medical Section of the American Lung Association. Guidelines for fiberoptic bronchoscopy in adults. Am Rev Respir Dis 1987;136:1066.
25. Sheridan JT, Gilmore RC, Watson MJ, Archer CB, Tarran R. 17b-Estradiol inhibits phosphorylation of stromal interaction molecule 1 (STIM1) protein: Implication for store-operated calcium entry and chronic lung diseases. J Biol Chem 2013;288:33509-33518.
26. Rowell TR, Reeber SL, Lee SL, Harris RA, Nethery RC, Herring AH, et al. Flavored e-cigarette liquids reduce proliferation and viability in the CALU3 airway epithelial cell line. Am J Physiol Lung Cell Mol Physiol 2017;313:L52-L66.
27. Rahman I, De Cunto G, Sundar IK, Lungarella G. Vulnerability and genetic susceptibility to cigarette smoke-induced emphysema in mice. Am J Respir Cell Mol Biol 2017;57:270-271.
28. Garcia-Arcos I, Geraghty P, Baumlin N, Campos M, Dabo AJ, Jundi B, et al. Chronic electronic cigarette exposure in mice induces features of COPD in a nicotine-dependent manner. Thorax 2016;71:1119-1129.
29. Davis ES, Sassano MF, Goodell H, Tarran R. E-liquid autofluorescence can be used as a marker of vaping deposition and third-hand vape exposure. Sci Rep 2017;7:7459.
30. Langner M, Hui SW. Merocyanine 540 as a fluorescence indicator for molecular packing stress at the onset of lamellar-hexagonal transition of phosphatidylethanolamine bilayers. Biochim Biophys Acta 1999;1415:323-330.
31. Breitling LP, Yang R, Korn B, Burwinkel B, Brenner H. Tobaccosmoking-related differential DNA methylation: 27K discovery and replication. Am J Hum Genet 2011;88:450-457.
32. Steiling K, Kadar AY, Bergerat A, Flanigon J, Sridhar S, Shah V, et al. Comparison of proteomic and transcriptomic profiles in the bronchial airway epithelium of current and never smokers. PLoS One 2009;4:e5043.
33. Davis CW, Dickey BF. Regulated airway goblet cell mucin secretion. Annu Rev Physiol 2008;70:487-512.
34. Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, Buzatu L, et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004;350:2645-2653.
35. Innes AL, Woodruff PG, Ferrando RE, Donnelly S, Dolganov GM, Lazarus SC, et al. Epithelial mucin stores are increased in the large airways of smokers with airflow obstruction. Chest 2006;130:1102-1108.
36. Yaucher NE, Fish JT, Smith HW, Wells JA. Propylene glycol-associated renal toxicity from lorazepam infusion. Pharmacotherapy 2003;23: 1094-1099.
37. Doi AM, Roycroft JH, Herbert RA, Haseman JK, Hailey JR, Chou BJ, et al. Inhalation toxicology and carcinogenesis studies of propylene glycol mono-t-butyl ether in rats and mice. Toxicology 2004;199: 1-22.
38. Blake DA, Whikehart DR, Yu H, Vogel T, Roberts DD. Common cryopreservation media deplete corneal endothelial cell plasma membrane Na1, K1 ATPase activity. Curr Eye Res 1996;15: 263-271.
39. Morshed KM, Jain SK, McMartin KE. Acute toxicity of propylene glycol: An assessment using cultured proximal tubule cells of human origin. Fundam Appl Toxicol 1994;23:38-43.
40. Madeira A, Moura TF, Soveral G. Aquaglyceroporins: Implications in adipose biology and obesity. Cell Mol Life Sci 2015;72:759-771.
41. Pocivavsek L, Gavrilov K, Cao KD, Chi EY, Li D, Lin B, et al. Glycerolinduced membrane stiffening: The role of viscous fluid adlayers. Biophys J 2011;101:118-127.
42. Verkman AS. Aquaporins in clinical medicine. Annu Rev Med 2012;63: 303-316.
43. Kreda SM, Gynn MC, Fenstermacher DA, Boucher RC, Gabriel SE. Expression and localization of epithelial aquaporins in the adult human lung. Am J Respir Cell Mol Biol 2001;24:224-234.
44. Malajczuk CJ, Hughes ZE, Mancera RL. Molecular dynamics simulations of the interactions of DMSO, mono- and polyhydroxylated cryosolvents with a hydrated phospholipid bilayer. Biochim Biophys Acta 2013;1828:2041-2055.
45. György B, SzabóTG, Pásztói M, Pál Z, Misják P, Aradi B, et al. Membrane vesicles, current state-of-the-art: Emerging role of extracellular vesicles. Cell Mol Life Sci 2011;68:2667-2688.
46. Sosnowski TR, Kramek-Romanowska K. Predicted deposition of e-cigarette aerosol in the human lungs. J Aerosol Med Pulm Drug Deliv 2016;29:299-309.
47. Lodovici M, Luceri C, Guglielmi F, Bacci C, Akpan V, Fonnesu ML, et al. Benzo(a)pyrene diolepoxide (BPDE)-DNA adduct levels in leukocytes of smokers in relation to polymorphism of CYP1A1, GSTM1, GSTP1, GSTT1, and mEH. Cancer Epidemiol Biomarkers Prev 2004;13: 1342-1348.
48. Nebert DW, Dalton TP. The role of cytochrome P450 enzymes in endogenous signalling pathways and environmental carcinogenesis. Nat Rev Cancer 2006;6:947-960.
49. Pastorelli R, Guanci M, Cerri A, Negri E, La Vecchia C, Fumagalli F, et al. Impact of inherited polymorphisms in glutathione S-transferase M1, microsomal epoxide hydrolase, cytochrome P450 enzymes on DNA, and blood protein adducts of benzo(a)pyrene-diolepoxide. Cancer Epidemiol Biomarkers Prev 1998;7:703-709.
50. Doostdar H, Burke MD, Mayer RT. Bioflavonoids: Selective substrates and inhibitors for cytochrome P450 CYP1A and CYP1B1. Toxicology 2000;144:31-38.
51. Lewis DF, Gillam EM, Everett SA, Shimada T. Molecular modelling of human CYP1B1 substrate interactions and investigation of allelic variant effects on metabolism. Chem Biol Interact 2003;145:281-295.
52. Shimada T, Gillam EM, Sutter TR, Strickland PT, Guengerich FP, Yamazaki H. Oxidation of xenobiotics by recombinant human cytochrome P450 1B1. Drug Metab Dispos 1997;25:617-622.
53. Pearson JL, Richardson A, Niaura RS, Vallone DM, Abrams DB. e-Cigarette awareness, use, and harm perceptions in US adults. Am J Public Health 2012;102:1758-1766.
54. Harraz OF, Altier C. STIM1-mediated bidirectional regulation of Ca21 entry through voltage-gated calcium channels (VGCC) and calcium-release activated channels (CRAC). Front Cell Neurosci 2014;8:43.
55. Liu L, Botos I, Wang Y, Leonard JN, Shiloach J, Segal DM, et al. Structural basis of Toll-like receptor 3 signaling with double-stranded RNA. Science 2008;320:379-381.
56. Beane J, Sebastiani P, Liu G, Brody JS, Lenburg ME, Spira A. Reversible and permanent effects of tobacco smoke exposure on airway epithelial gene expression. Genome Biol 2007;8:R201.
57. Yeh JS, Bullen C, Glantz SA. Clinical decisions: E-cigarettes and smoking cessation. N Engl J Med 2016;374:2172-2174.